JP2014171441A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014171441A5 JP2014171441A5 JP2013047508A JP2013047508A JP2014171441A5 JP 2014171441 A5 JP2014171441 A5 JP 2014171441A5 JP 2013047508 A JP2013047508 A JP 2013047508A JP 2013047508 A JP2013047508 A JP 2013047508A JP 2014171441 A5 JP2014171441 A5 JP 2014171441A5
- Authority
- JP
- Japan
- Prior art keywords
- test substance
- wrinkle formation
- expression level
- gene
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 11
- 239000000126 substance Substances 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 230000037373 wrinkle formation Effects 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 4
- 230000002757 inflammatory effect Effects 0.000 claims 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 210000001339 epidermal cell Anatomy 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims 1
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 claims 1
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 1
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims 1
- 101000852980 Homo sapiens Interleukin-23 subunit alpha Proteins 0.000 claims 1
- 101000853009 Homo sapiens Interleukin-24 Proteins 0.000 claims 1
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 claims 1
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims 1
- -1 IL1α Proteins 0.000 claims 1
- 108091058560 IL8 Proteins 0.000 claims 1
- 102000049772 Interleukin-16 Human genes 0.000 claims 1
- 101800003050 Interleukin-16 Proteins 0.000 claims 1
- 102100036705 Interleukin-23 subunit alpha Human genes 0.000 claims 1
- 102100036671 Interleukin-24 Human genes 0.000 claims 1
- 102000004890 Interleukin-8 Human genes 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 102100026894 Lymphotoxin-beta Human genes 0.000 claims 1
- 102100040557 Osteopontin Human genes 0.000 claims 1
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- FOCAHLGSDWHSAH-UHFFFAOYSA-N difluoromethanethione Chemical compound FC(F)=S FOCAHLGSDWHSAH-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013047508A JP6192318B2 (ja) | 2013-03-11 | 2013-03-11 | シワ形成抑制剤及び／又は抗炎症剤のスクリーニング法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013047508A JP6192318B2 (ja) | 2013-03-11 | 2013-03-11 | シワ形成抑制剤及び／又は抗炎症剤のスクリーニング法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014171441A JP2014171441A (ja) | 2014-09-22 |
| JP2014171441A5 true JP2014171441A5 (enExample) | 2016-04-14 |
| JP6192318B2 JP6192318B2 (ja) | 2017-09-06 |
Family
ID=51693417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013047508A Active JP6192318B2 (ja) | 2013-03-11 | 2013-03-11 | シワ形成抑制剤及び／又は抗炎症剤のスクリーニング法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6192318B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7206725B2 (ja) * | 2018-09-14 | 2023-01-18 | ポーラ化成工業株式会社 | 肌状態改善剤のスクリーニング方法 |
| CN117357419B (zh) * | 2023-09-27 | 2025-11-28 | 花安堂生物科技集团有限公司 | 一种抗衰蛋白或其重组蛋白在制备化妆品中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007135510A (ja) * | 2005-11-21 | 2007-06-07 | Shiseido Co Ltd | Ａｄａｍ活性阻害剤のスクリーニング方法 |
| KR100879558B1 (ko) * | 2007-07-31 | 2009-01-22 | 라이브켐 주식회사 | 디벤조파라디옥신 유도체를 유효성분으로 함유한 피부보호 및 개선제 |
| JP2011101663A (ja) * | 2009-11-10 | 2011-05-26 | Shiseido Co Ltd | シワの形成し易さの評価方法 |
| JP2012250968A (ja) * | 2011-06-01 | 2012-12-20 | Momotani Juntendo:Kk | マトリックスメタロプロテアーゼ−１産生抑制剤及び／又はコラーゲン産生促進剤 |
-
2013
- 2013-03-11 JP JP2013047508A patent/JP6192318B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hesslein et al. | Transcriptional control of natural killer cell development and function | |
| JP2012236016A5 (enExample) | ||
| CL2015000966A1 (es) | Combinaciones de compuestos activos que comprenden derivados de carboxamida y un agente de control biológico; composiciones que las comprenden; método de control de hongos fitopatógenos en cultivos que las utiliza; y uso de las combinaciones y composiciones. | |
| CL2014002757A1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer. | |
| JP2014507482A5 (enExample) | ||
| JP2015512729A5 (enExample) | ||
| JP2013517328A5 (enExample) | ||
| CL2008000188A1 (es) | Agente para suprimir la reaccion de rechazo cronica que comprende como ingrediente activo un inhibidor de il-6; y uso del inhibidor de il-6. | |
| IT1402907B1 (it) | Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose. | |
| PL3313991T3 (pl) | Modyfikowany czynnik ix oraz kompozycje, sposoby i zastosowania do transferu genów do komórek, narządów i tkanek | |
| WO2011156030A3 (en) | High oil-content emollient aerosol foam compositions | |
| CL2014001070A1 (es) | Compuestos derivados de aminoácidos funcionalizados en el n-terminal, capaces de formar micro- o nanopartículas para encapsular un agente; composición; uso para tratar enfermedades; y método de suministro de un polinucleótido a una célula. | |
| HK1208361A1 (en) | Multi-target modulation for treating fibrosis and inflammatory conditions | |
| BR112013018352A2 (pt) | composição de minociclina tópica e método | |
| JP2012144538A5 (enExample) | ||
| JP2012193275A5 (enExample) | ||
| WO2012131083A8 (en) | Composition comprising perlite and a polymer bearing a carbosiloxane dendrimer-based unit | |
| CL2015001678A1 (es) | Compuestos derivados de 4-{7-metil-3-oxo-8-[3-(trifluoromeil)ciclohexa-2,4-dien-1-il]-2,3,5,8-tetrahidro[1,2,4]triazolo[4,3-a]pirimidin-5-il}benzonitrilo; composicion farmaceutica; un metodo para tratar una enfermedad o una afeccion en la que participa hne, tal como epoc, neumonia, asma, rinitis, entre otras. | |
| FR2975004B1 (fr) | Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant | |
| JP2020504178A5 (enExample) | ||
| PL3305751T3 (pl) | Zastosowanie kompozycji azeotropowych trans-1,1,1,4,4,4-heksafluoro-2-butenu i wody | |
| WO2014043230A3 (en) | Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| JP2014171441A5 (enExample) | ||
| JP2015535241A5 (enExample) |